1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Nasal Delivery Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Nasal Delivery Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Nasal Delivery Devices Market Regional Analysis
6.2 Europe Nasal Delivery Devices Market Revenue 2017-2027 (US$ Million)
6.3 Europe Nasal Delivery Devices Market Forecast Analysis
7. Europe Nasal Delivery Devices Market Analysis – by Drug Type
7.1 Anaesthetics
- 7.1.1 Overview
- 7.1.2 Anaesthetics: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Antibiotics
- 7.2.1 Overview
- 7.2.2 Antibiotics: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Pain Relief Drugs
- 7.3.1 Overview
- 7.3.2 Pain Relief Drugs: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Calcium Supplements
- 7.4.1 Overview
- 7.4.2 Calcium Supplements: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Vasoconstrictors
- 7.5.1 Overview
- 7.5.2 Vasoconstrictors: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Antihistamines
- 7.6.1 Overview
- 7.6.2 Antihistamines: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Nasal Delivery Devices Market Analysis – by Delivery Technologies
8.1 Spray
- 8.1.1 Overview
- 8.1.2 Spray: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Nebulizers
- 8.2.1 Overview
- 8.2.2 Nebulizers: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Inhalers
- 8.3.1 Overview
- 8.3.2 Inhalers: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Nasal Delivery Devices Market Analysis – by End User
9.1 Home Care Settings
- 9.1.1 Overview
- 9.1.2 Home Care Settings: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Hospitals
- 9.2.1 Overview
- 9.2.2 Hospitals: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Clinics
- 9.3.1 Overview
- 9.3.2 Clinics: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Europe Nasal Delivery Devices Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Nasal Delivery Devices Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 Europe Nasal Delivery Devices Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 UK: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.1.2 UK: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.1.3 UK: Europe Nasal Delivery Devices Market Breakdown, by End User
- 10.2.1.2 Germany:
Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Germany: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.2.2 Germany: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.2.3 Germany: Europe Nasal Delivery Devices Market Breakdown, by End User
- 10.2.1.3 France:
Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 France: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.3.2 France: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.3.3 France: Europe Nasal Delivery Devices Market Breakdown, by End User
- 10.2.1.4 Russia:
Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Russia: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.4.2 Russia: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.4.3 Russia: Europe Nasal Delivery Devices Market Breakdown, by End User
- 10.2.1.5 Italy:
Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.5.1 Italy: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.5.2 Italy: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.5.3 Italy: Europe Nasal Delivery Devices Market Breakdown, by End User
- 10.2.1.6 Rest of Europe:
Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.6.2 Rest of Europe: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.6.3 Rest of Europe: Europe Nasal Delivery Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 GlaxoSmithKline plc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AstraZeneca
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Pfizer Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BD
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Sanofi
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck & Co., Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Cadila Pharmaceuticals Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Novartis AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Dr. Reddy's Laboratories
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations